UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 73

Sortiert nach

A 1 adenosine receptor agonists and their potential therapeutic applications

Expert opinion on investigational drugs, 2008-12, Vol.17 (12), p.1901-1910

2008

Link zum Volltext

Verfügbarkeit prüfen

2-Pyrazolyl-N 6 -Substituted Adenosine Derivatives as High Affinity and Selective Adenosine A 3 Receptor Agonists

Journal of medicinal chemistry, 2004-09, Vol.47 (19), p.4766-4773

2004

Link zum Volltext

Verfügbarkeit prüfen

2-Pyrazolyl-N(6)-substituted adenosine derivatives as high affinity and selective adenosine A(3) receptor agonists

Journal of medicinal chemistry, 2004-09, Vol.47 (19), p.4766-4773

2004

Link zum Volltext

Verfügbarkeit prüfen

2-Pyrazolyl-N6-Substituted Adenosine Derivatives as High Affinity and Selective Adenosine A3 Receptor Agonists

Journal of medicinal chemistry, 2004-09, Vol.47 (19), p.4766-4773

2004

Link zum Volltext

Verfügbarkeit prüfen

A 2B adenosine receptor antagonists and their potential indications

Expert opinion on therapeutic patents, 2006-10, Vol.16 (10), p.1347-1357

2006

Link zum Volltext

Verfügbarkeit prüfen

A1 adenosine receptor agonists and their potential therapeutic applications

Expert opinion on investigational drugs, 2008-12, Vol.17 (12), p.1901-1910

2008

Link zum Volltext

Verfügbarkeit prüfen

A1 adenosine receptor antagonists, agonists, and allosteric enhancers

Handbook of experimental pharmacology, 2009 (193), p.25

2009

Link zum Volltext

Verfügbarkeit prüfen

A2B adenosine receptor antagonists and their potential indications

Expert opinion on therapeutic patents, 2006-10, Vol.16 (10), p.1347-1357

2006

Link zum Volltext

Verfügbarkeit prüfen

Addendum: Inhibition of aldehyde dehydrogenase-2 suppresses cocaine seeking by generating THP, a cocaine use–dependent inhibitor of dopamine synthesis

Nature medicine, 2011-02, Vol.17 (2), p.229-229

2011

Link zum Volltext

Verfügbarkeit prüfen

Affinity and intrinsic efficacy (IE) of 5′-carbamoyl adenosine analogues for the A 1 adenosine receptor—efforts towards the discovery of a chronic ventricular rate control agent for the treatment of atrial fibrillation (AF)

Bioorganic & medicinal chemistry letters, 2004, Vol.14 (2), p.535-539

2004

Link zum Volltext

Verfügbarkeit prüfen

Affinity and intrinsic efficacy (IE) of 5'-carbamoyl adenosine analogues for the A1 adenosine receptor: efforts towards the discovery of a chronic ventricular rate control agent for the treatment of atrial fibrillation (AF)

Bioorganic & medicinal chemistry letters, 2004-01, Vol.14 (2), p.535-539

2004

Link zum Volltext

Verfügbarkeit prüfen

Chapter 13 Recent Advances in Adenosine Receptor (AR) Ligands in Pulmonary Diseases

Annual Reports in Medicinal Chemistry, 2009, Vol.44, p.265-277

2009

Link zum Volltext

Verfügbarkeit prüfen

Characterization of the potency, selectivity, and pharmacokinetic profile for six adenosine A2A receptor antagonists

Naunyn-Schmiedeberg's archives of pharmacology, 2007-04, Vol.375 (2), p.133-144

2007

Link zum Volltext

Verfügbarkeit prüfen

CVT-4325: A Potent Fatty Acid Oxidation Inhibitor with Favorable Oral Bioavailability

ChemInform, 2005-04, Vol.36 (15), p.no-no

2005

Link zum Volltext

Verfügbarkeit prüfen

CVT-4325: a potent fatty acid oxidation inhibitor with favorable oral bioavailability

Bioorganic & medicinal chemistry letters, 2004-12, Vol.14 (24), p.6017-6021

2004

Link zum Volltext

Verfügbarkeit prüfen

Discovery of a Novel A 2B Adenosine Receptor Antagonist as a Clinical Candidate for Chronic Inflammatory Airway Diseases

Journal of medicinal chemistry, 2008-04, Vol.51 (7), p.2267-2278

2008

Link zum Volltext

Verfügbarkeit prüfen

Discovery of a Novel A2B Adenosine Receptor Antagonist as a Clinical Candidate for Chronic Inflammatory Airway Diseases

Journal of medicinal chemistry, 2008-04, Vol.51 (7), p.2267-2278

2008

Link zum Volltext

Verfügbarkeit prüfen

The Discovery of a Selective, High Affinity A 2B Adenosine Receptor Antagonist for the Potential Treatment of Asthma

ChemInform, 2005-06, Vol.36 (25)

Zablocki, Jeff

2005

Link zum Volltext

Verfügbarkeit prüfen

The discovery of a selective, high affinity A(2B) adenosine receptor antagonist for the potential treatment of asthma

Bioorganic & medicinal chemistry letters, 2005-02, Vol.15 (3), p.609-612

2005

Link zum Volltext

Verfügbarkeit prüfen

The discovery of a selective, high affinity A 2B adenosine receptor antagonist for the potential treatment of asthma

Bioorganic & medicinal chemistry letters, 2005, Vol.15 (3), p.609-612

2005

Link zum Volltext

Verfügbarkeit prüfen

The discovery of a selective, high affinity A2B adenosine receptor antagonist for the potential treatment of asthma

Bioorganic & medicinal chemistry letters, 2005-02, Vol.15 (3), p.609-612

2005

Link zum Volltext

Verfügbarkeit prüfen

The Discovery of a Selective, High Affinity A2B Adenosine Receptor Antagonist for the Potential Treatment of Asthma

ChemInform, 2005-06, Vol.36 (25), p.no-no

2005

Link zum Volltext

Verfügbarkeit prüfen

Discovery of Dihydrobenzoxazepinone (GS-6615) Late Sodium Current Inhibitor (Late I Nai), a Phase II Agent with Demonstrated Preclinical Anti-Ischemic and Antiarrhythmic Properties

Journal of medicinal chemistry, 2016-10, Vol.59 (19), p.9005-9017

2016

Link zum Volltext

Verfügbarkeit prüfen

Discovery of GS-9688 (Selgantolimod) as a Potent and Selective Oral Toll-Like Receptor 8 Agonist for the Treatment of Chronic Hepatitis B

Journal of medicinal chemistry, 2020-09, Vol.63 (18), p.10188-10203

2020

Link zum Volltext

Verfügbarkeit prüfen

Discovery of potent and selective inhibitors of calmodulin-dependent kinase II (CaMKII)

Bioorganic & medicinal chemistry letters, 2018-02, Vol.28 (3), p.541-546

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 73

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(67)
Mit Volltextzugriff
(63)

Publikationsform

Artikel
(71)
Buchkapitel
(2)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(26)
Animals
(25)
Life Sciences & Biomedicine
(22)
Science & Technology
(22)
Pharmacology & Pharmacy
(17)
Structure-Activity Relationship
(17)
Chemistry, Medicinal
(15)
Rats
(13)
Molecular Structure
(12)
Physical Sciences
(12)
Biological And Medical Sciences
(11)
Chemistry
(11)
Chemistry, Organic
(11)
Medical Sciences
(11)
Pharmacology. Drug Treatments
(10)
Dose-Response Relationship, Drug
(9)
Xanthines - Pharmacology
(8)
Adenosine A2 Receptor Antagonists
(7)
Neuropharmacology
(7)
Neurotransmitters. Neurotransmission. Receptors
(7)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A 1 adenosine receptor agonists and their potential therapeutic applications

2-Pyrazolyl-N 6 -Substituted Adenosine Derivatives as High Affinity and Selective Adenosine A 3 Receptor Agonists

2-Pyrazolyl-N(6)-substituted adenosine derivatives as high affinity and selective adenosine A(3) receptor agonists

2-Pyrazolyl-N6-Substituted Adenosine Derivatives as High Affinity and Selective Adenosine A3 Receptor Agonists

A 2B adenosine receptor antagonists and their potential indications

A1 adenosine receptor agonists and their potential therapeutic applications

A1 adenosine receptor antagonists, agonists, and allosteric enhancers

A2B adenosine receptor antagonists and their potential indications

Addendum: Inhibition of aldehyde dehydrogenase-2 suppresses cocaine seeking by generating THP, a cocaine use–dependent inhibitor of dopamine synthesis

Affinity and intrinsic efficacy (IE) of 5′-carbamoyl adenosine analogues for the A 1 adenosine receptor—efforts towards the discovery of a chronic ventricular rate control agent for the treatment of atrial fibrillation (AF)

Affinity and intrinsic efficacy (IE) of 5'-carbamoyl adenosine analogues for the A1 adenosine receptor: efforts towards the discovery of a chronic ventricular rate control agent for the treatment of atrial fibrillation (AF)

Chapter 13 Recent Advances in Adenosine Receptor (AR) Ligands in Pulmonary Diseases

Characterization of the potency, selectivity, and pharmacokinetic profile for six adenosine A2A receptor antagonists

CVT-4325: A Potent Fatty Acid Oxidation Inhibitor with Favorable Oral Bioavailability

CVT-4325: a potent fatty acid oxidation inhibitor with favorable oral bioavailability

Discovery of a Novel A 2B Adenosine Receptor Antagonist as a Clinical Candidate for Chronic Inflammatory Airway Diseases

Discovery of a Novel A2B Adenosine Receptor Antagonist as a Clinical Candidate for Chronic Inflammatory Airway Diseases

The Discovery of a Selective, High Affinity A 2B Adenosine Receptor Antagonist for the Potential Treatment of Asthma

The discovery of a selective, high affinity A(2B) adenosine receptor antagonist for the potential treatment of asthma

The discovery of a selective, high affinity A 2B adenosine receptor antagonist for the potential treatment of asthma

The discovery of a selective, high affinity A2B adenosine receptor antagonist for the potential treatment of asthma

The Discovery of a Selective, High Affinity A2B Adenosine Receptor Antagonist for the Potential Treatment of Asthma

Discovery of Dihydrobenzoxazepinone (GS-6615) Late Sodium Current Inhibitor (Late I Nai), a Phase II Agent with Demonstrated Preclinical Anti-Ischemic and Antiarrhythmic Properties

Discovery of GS-9688 (Selgantolimod) as a Potent and Selective Oral Toll-Like Receptor 8 Agonist for the Treatment of Chronic Hepatitis B

Discovery of potent and selective inhibitors of calmodulin-dependent kinase II (CaMKII)

Suchergebnisse filtern